Anisa Rista
Family Medicine · Euclid, OHNPI 1659011013
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.8% of the total across 98 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AstraZeneca at 25.5% of the total. 2025 is the largest year on record at $1,874, 7.7 times the $243 reported in 2022.
Across 98 payments — averaging $39.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$978
- AbbVie$467
- Phathom Pharmaceuticals, Inc.$401
- Astellas Pharma US Inc$321
- Exact Sciences$274
- Lilly USA, LLC$274
- plus $1K from 17 others
What the payments were for
- Food & beverage$3,63495%
- Education$1995%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 15 | $978 |
| AbbVie | 18 | $467 |
| Phathom Pharmaceuticals, Inc. | 9 | $401 |
| Astellas Pharma US Inc | 9 | $321 |
| Exact Sciences | 5 | $274 |
| Lilly USA, LLC | 7 | $274 |
| Amgen | 4 | $257 |
| UCB, Inc. | 1 | $125 |
| Sanofi-aventis U.S. LLC | 1 | $116 |
| Atricure, Inc. | 1 | $100 |
| GSK | 4 | $78 |
| Novo Nordisk | 4 | $64 |
| Bayer | 3 | $62 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $62 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $53 |
| Merck | 3 | $42 |
| Azurity Pharmaceuticals, Inc. | 2 | $37 |
| Radius Health, Inc. | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Sanofi | 1 | $20 |
| Genentech USA, Inc. | 1 | $20 |
| Amneal Pharmaceuticals LLC | 1 | $19 |
| Sanofi Pasteur Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,833 in reported general payments places this provider in the 85th percentile of 3,983 family medicine providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Olmesartan Medoxomil | 13 | $239 |
| Amlodipine Besylate | 27 | $117 |
| Atorvastatin Calcium | 11 | $111 |
| Losartan Potassium | 12 | $75 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Euclid
- Kwabena OtengSpringdale$2M
- Brian BeesleyColumbus$1.4M
- Darshana PatelBeachwood$648K
- Thomas GraceFindlay$503K
- Susan RatayAshtabula$379K
- Shannon TrotterSpringfield$348K
- Michael HeileCincinnati$272K
- Bradley EverlyMaumee$266K
- Tricia BedrickCuyahoga Falls$259K
- David NeidhardtLima$248K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.